Shopping Cart
- Remove All
- Your shopping cart is currently empty
TTT 3002, an orally active and potent FLT3 inhibitor, efficiently suppresses FLT3 phosphorylation triggered by activating mutations at residue D835, showcasing an IC50 value of 0.2 nM. This compound is primarily utilized in acute myeloid leukemia (AML) research.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $3,770 | 10-14 weeks | |
50 mg | $4,980 | 10-14 weeks | |
100 mg | $7,000 | 10-14 weeks |
Description | TTT 3002, an orally active and potent FLT3 inhibitor, efficiently suppresses FLT3 phosphorylation triggered by activating mutations at residue D835, showcasing an IC50 value of 0.2 nM. This compound is primarily utilized in acute myeloid leukemia (AML) research. |
Molecular Weight | 465.50 |
Formula | C27H23N5O3 |
Cas No. | 871037-95-5 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.